High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Peripheral blood lymphocytes (PBLs) are primary targets for gene therapy of inherited and acquired disorders of the immune system. We describe the development of an optimized transduction system that provides for high-efficiency retrovirus-mediated gene transfer into primary PBLs. This optimized transduction protocol combines centrifugation of the lymphocytes (1000 x g) at the inception of transduction with phosphate depletion, low-temperature incubation (32 degrees C), and the use of the packaging cell line PG13. Gene marking studies of human and primate PBLs using these optimized transduction conditions demonstrated that the transduction efficiency exceeded 50% of the total lymphocyte population. The optimized transduction efficiency of PBLs with amphotropic retroviral vectors was in excess of 25%. The transduction procedure does not alter phenotype, viability, or expansion of the transduced cells. Our data indicate that this optimized transduction system leads to high-efficiency gene transfer into primary human lymphocytes, which obviates the requirement for selection of transduced cells prior to gene-therapy procedures. Thus, large quantities of healthy retrovirally transduced lymphocytes containing a broad immunological repertoire can be generated for use in clinical protocols. Our results represent a significant improvement in the methodology for the transduction of lymphocytes for gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved retroviral vectors for gene transfer and expression.
Miller, A. D., & Rosman, G. J. (1989) · PubMed · Cited by 1,971
Miller, A. D., & Buttimore, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.8.2895 · Cited by 1,370
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus
Miller, A. D., Garcia, J. V., von Suhr, N., Lynch, C. M., Wilson, C., & Eiden, M. V. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2220-2224.1991 · Cited by 627
Kavanaugh, M. P., Miller, D. G., Zhang, W., Law, W., Kozak, S. L., Kabat, D., & Miller, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7071 · Cited by 586
Improved Methods of Retroviral Vector Transduction and Production for Gene Therapy
Kotani, H., Newton, P. B., Zhang, S., Chiang, Y. L., Otto, E., Weaver, L., Blaese, R. M., Anderson, W. F., & McGarrity, G. J. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.1-19 · Cited by 370
Self-citationMorgan, R. A., & Anderson, W. F. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.001203 · Cited by 264
Self-citationPeripheral blood lymphocytes as target cells of retroviral vector- mediated gene transfer
Mavilio, F., Ferrari, G., Rossini, S., Nobili, N., Bonini, C., Casorati, G., Traversari, C., & Bordignon, C. (1994) · Blood · doi:10.1182/blood.v83.7.1988.1988 · Cited by 239
Anderson, W. F. (1992) · Science · doi:10.1126/science.256.5058.808 · Cited by 227
Points to Consider Response with Clinical Protocol, July 6, 1990
Anderson, W. F., Blaese, R. M., & Culver, K. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.3-331 · Cited by 218
Self-citationJohann, S. V., Gibbons, J. J., & O'Hara, B. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1635-1640.1992 · Cited by 154
Kasid, A., Morecki, S., Aebersold, P. M., Cornetta, K. G., Culver, K. W., Freeman, S., Director, E. P., Lotze, M. T., Blaese, R. M., & Anderson, W. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.473 · Cited by 145
Self-citationLymphocytes as cellular vehicles for gene therapy in mouse and man.
Culver, K. W., Cornetta, K. G., Morgan, R., Morecki, S., Aebersold, P. M., Kasid, A., Lotze, M. T., Rosenberg, S. A., Anderson, W. F., & Blaese, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3155 · Cited by 140
Self-citationGoodman, S., Xiao, X., Donahue, R., Moulton, A., Miller, J., Walsh, C., Young, N., Samulski, R., & Nienhuis, A. (1994) · Blood · doi:10.1182/blood.v84.5.1492.bloodjournal8451492 · Cited by 109
Self-citationMorgan, R. A., Cornetta, K. G., & Anderson, W. F. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.2-135 · Cited by 91
Self-citationIn Vivo Expression and Survival of Gene-Modified T Lymphocytes in Rhesus Monkeys
Culver, K. W., Morgan, R. A., Osborne, W. R. A., Lee, R. T., Lenschow, D. J., Able, C., Cornetta, K. G., Anderson, W. F., & Blaese, R. M. (1990) · Human Gene Therapy · doi:10.1089/hum.1990.1.4-399 · Cited by 52
Self-citation
Cited by
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
Self-citationThe Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410
NICHOLS, W. L., HULTIN, M. B., JAMES, A. H., MANCO‐JOHNSON, M. J., MONTGOMERY, R. R., ORTEL, T. L., RICK, M. E., SADLER, J. E., WEINSTEIN, M., & YAWN, B. P. (2008) · Haemophilia · doi:10.1111/j.1365-2516.2007.01643.x · Cited by 967
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
O'Doherty, U., Swiggard, W. J., & Malim, M. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10074-10080.2000 · Cited by 664
Metadata
- Authors
- Bunnell, B. A., Muul, L. M., Donahue, R. E., Blaese, R. M., & Morgan, R. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-08-15
- Volume
- 92
- Issue
- 17
- Pages
- 7739-7743
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1981686597
- Cited by
- 258
- References
- 15
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.